Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HDX0
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 10 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016311 | dephosphorylation | 5 | 11 |
GO:0019538 | protein metabolic process | 3 | 10 |
GO:0036211 | protein modification process | 4 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0043412 | macromolecule modification | 4 | 10 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 10 |
GO:0016310 | phosphorylation | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 11 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 11 |
GO:0016791 | phosphatase activity | 5 | 11 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 8 | 1 |
GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity | 7 | 1 |
GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity | 7 | 1 |
GO:0052866 | phosphatidylinositol phosphate phosphatase activity | 6 | 1 |
GO:0106019 | phosphatidylinositol-4,5-bisphosphate phosphatase activity | 8 | 1 |
GO:0016301 | kinase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 295 | 299 | PF00656 | 0.354 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.335 |
CLV_NRD_NRD_1 | 227 | 229 | PF00675 | 0.423 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.548 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.368 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.464 |
CLV_PCSK_PC1ET2_1 | 154 | 156 | PF00082 | 0.368 |
CLV_PCSK_PC1ET2_1 | 44 | 46 | PF00082 | 0.454 |
CLV_PCSK_SKI1_1 | 294 | 298 | PF00082 | 0.615 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.644 |
DOC_CYCLIN_RxL_1 | 289 | 299 | PF00134 | 0.464 |
DOC_MAPK_gen_1 | 154 | 161 | PF00069 | 0.265 |
DOC_MAPK_gen_1 | 226 | 234 | PF00069 | 0.320 |
DOC_MAPK_MEF2A_6 | 154 | 163 | PF00069 | 0.330 |
DOC_MAPK_RevD_3 | 214 | 229 | PF00069 | 0.284 |
DOC_USP7_MATH_1 | 275 | 279 | PF00917 | 0.314 |
DOC_USP7_MATH_1 | 64 | 68 | PF00917 | 0.550 |
DOC_WW_Pin1_4 | 206 | 211 | PF00397 | 0.386 |
LIG_14-3-3_CanoR_1 | 155 | 160 | PF00244 | 0.486 |
LIG_14-3-3_CanoR_1 | 228 | 233 | PF00244 | 0.404 |
LIG_14-3-3_CanoR_1 | 280 | 290 | PF00244 | 0.421 |
LIG_14-3-3_CanoR_1 | 45 | 51 | PF00244 | 0.518 |
LIG_14-3-3_CanoR_1 | 80 | 86 | PF00244 | 0.418 |
LIG_APCC_ABBA_1 | 191 | 196 | PF00400 | 0.193 |
LIG_BRCT_BRCA1_1 | 7 | 11 | PF00533 | 0.642 |
LIG_eIF4E_1 | 93 | 99 | PF01652 | 0.365 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.539 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.337 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.398 |
LIG_FHA_1 | 229 | 235 | PF00498 | 0.404 |
LIG_FHA_2 | 10 | 16 | PF00498 | 0.586 |
LIG_FHA_2 | 217 | 223 | PF00498 | 0.193 |
LIG_FHA_2 | 31 | 37 | PF00498 | 0.502 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.504 |
LIG_FHA_2 | 71 | 77 | PF00498 | 0.519 |
LIG_LIR_Gen_1 | 196 | 203 | PF02991 | 0.341 |
LIG_LIR_Gen_1 | 243 | 251 | PF02991 | 0.233 |
LIG_LIR_Nem_3 | 184 | 190 | PF02991 | 0.281 |
LIG_LIR_Nem_3 | 196 | 200 | PF02991 | 0.251 |
LIG_PDZ_Class_3 | 322 | 327 | PF00595 | 0.438 |
LIG_Pex14_2 | 282 | 286 | PF04695 | 0.341 |
LIG_SH2_PTP2 | 197 | 200 | PF00017 | 0.205 |
LIG_SH2_STAT3 | 20 | 23 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.210 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 233 | 236 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.360 |
LIG_SH3_3 | 195 | 201 | PF00018 | 0.284 |
LIG_SUMO_SIM_anti_2 | 261 | 267 | PF11976 | 0.281 |
LIG_TRAF2_1 | 12 | 15 | PF00917 | 0.559 |
LIG_TRAF2_1 | 182 | 185 | PF00917 | 0.284 |
LIG_TYR_ITIM | 195 | 200 | PF00017 | 0.289 |
LIG_WRC_WIRS_1 | 47 | 52 | PF05994 | 0.412 |
MOD_CK2_1 | 216 | 222 | PF00069 | 0.321 |
MOD_CK2_1 | 255 | 261 | PF00069 | 0.270 |
MOD_CK2_1 | 28 | 34 | PF00069 | 0.482 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.442 |
MOD_CK2_1 | 70 | 76 | PF00069 | 0.609 |
MOD_CK2_1 | 9 | 15 | PF00069 | 0.609 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.441 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.276 |
MOD_GlcNHglycan | 6 | 10 | PF01048 | 0.683 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.608 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.650 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.430 |
MOD_GSK3_1 | 202 | 209 | PF00069 | 0.245 |
MOD_GSK3_1 | 292 | 299 | PF00069 | 0.365 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.567 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.586 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.319 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.341 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.382 |
MOD_NEK2_1 | 290 | 295 | PF00069 | 0.466 |
MOD_NEK2_1 | 296 | 301 | PF00069 | 0.503 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.412 |
MOD_OFUCOSY | 249 | 254 | PF10250 | 0.378 |
MOD_PIKK_1 | 133 | 139 | PF00454 | 0.442 |
MOD_PIKK_1 | 143 | 149 | PF00454 | 0.414 |
MOD_PIKK_1 | 273 | 279 | PF00454 | 0.316 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.558 |
MOD_PKA_1 | 228 | 234 | PF00069 | 0.335 |
MOD_Plk_1 | 14 | 20 | PF00069 | 0.560 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.488 |
MOD_Plk_2-3 | 28 | 34 | PF00069 | 0.579 |
MOD_Plk_4 | 228 | 234 | PF00069 | 0.390 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.464 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.374 |
MOD_ProDKin_1 | 206 | 212 | PF00069 | 0.386 |
MOD_SUMO_for_1 | 182 | 185 | PF00179 | 0.193 |
MOD_SUMO_rev_2 | 222 | 231 | PF00179 | 0.215 |
TRG_DiLeu_BaEn_1 | 186 | 191 | PF01217 | 0.335 |
TRG_DiLeu_BaEn_1 | 261 | 266 | PF01217 | 0.281 |
TRG_DiLeu_BaEn_1 | 53 | 58 | PF01217 | 0.603 |
TRG_DiLeu_LyEn_5 | 53 | 58 | PF01217 | 0.467 |
TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.289 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.428 |
TRG_ER_diArg_1 | 45 | 47 | PF00400 | 0.460 |
TRG_Pf-PMV_PEXEL_1 | 294 | 298 | PF00026 | 0.507 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8A1 | Leptomonas seymouri | 64% | 100% |
A0A0S4JDL0 | Bodo saltans | 48% | 87% |
A0A1X0P5C5 | Trypanosomatidae | 50% | 100% |
A0A3Q8IF49 | Leishmania donovani | 82% | 100% |
A0A3R7ME04 | Trypanosoma rangeli | 54% | 100% |
A4I165 | Leishmania infantum | 82% | 100% |
E9AX99 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4QA73 | Leishmania major | 80% | 100% |
V5B7P3 | Trypanosoma cruzi | 53% | 96% |